High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: Correlation with poor prognosis and CD4 expression on blast cells

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages

  Nakase, Kazunori ^a   Kita, Kenkichi ^b   Kyo, Taiichi ^c   Tsuji, Kota ^d   Katayama, Naoyuki ^e  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b Japan Baptist Hospital   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^d ISE RED CROSS HOSPITAL   (Japan)

^e MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myeloid leukemia; CD4; Soluble interleukin 2 receptor

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CHRONIC MYELOCYTIC LEUKEMIA IN BLAST CRISIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE;

ANTIGENS, CD4; ANTIGENS, SURFACE; BLAST CRISIS; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECEPTORS, INTERLEUKIN-2; SERUM; SURVIVAL RATE;

EID: 84865862544     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.03.011     Document Type: Article

References (17)

1. Sugamura K., Takeshita T., Asao H., Kumaki S., Ohbo K., Ohtani K., et al. The IL-2/IL-2 receptor system: involvement of a novel receptor subunit, gamma chain, in growth signal transduction. Tohoku J Exp Med 1992, 168:231-237.
2. Pui C.H. Serum interleukin 2 receptor: clinical and biological implications. Leukemia 1989, 3:323-327.
3. Pizzolo G., Chilosi M., Vinante F., Dazzi F., Lestani M., Perona G., et al. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's lymphoma. Br J Cancer 1987, 55:427-428.
4. Chilosi M., Semenzato G., Vinante F., Menestrina F., Piazzola E., Focchiatti V., et al. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Am J Clin Pathol 1989, 92:186-191.
5. Pizzolo G., Ambrosetti A., Vinante F., Chilosi M., Semenzato G. Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia. Blood 1991, 77:2540-2542.
6. Semenzato G., Foa R., Agastini C., Zambello R., Trentin L., Vinante F. High serum levels of interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987, 70:396-400.
7. Kamihira S., Atogami S., Sohda H., Momita S., Yamada Y., Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994, 73:2753-2758.
8. Nakase K., Kita K., Miwa H., Nishii K., Shikami M., Tanaka I., et al. Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosis. Leukemia 2007, 21:326-332.
9. Nakase K., Tsuji K., Tamaki S., Tanigawa M., Ikeda T., Miyanishi E., et al. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. Cancer Detect Prev 2005, 29:256-259.
10. Ohno R. Cooperative oncology groups in Japan: experience from the Japan Adult Leukemia Study Group. Cancer Chemother Pharmacol 1998, 42(Suppl.):S93-S97.
11. Pui C.H., Ip S.H., Iflah S., Behm F.G., Grose B.H., Dodge R.K., et al. Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood 1988, 71:1135-1137.
12. Nakase K., Kita K., Kageyama S., Tsuji K., Miyanishi E., Miwa H. Clinical importance of interleukin-2 receptor alpha chain expression in acute leukemia. The Japanese cooperative group of leukemia/lymphoma. Cancer Detect Prev 1997, 21:273-279.
13. Terwijn M., Feller M., van Rhenen A., Kelder A., Westra G., Zweegman S., et al. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. Eur J Cancer 2009, 45:1692-1699.
14. Pui C.H., Schell M.J., Vodian M.A., Kline S., Mirro J., Crist W.M., et al. Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia. Leukemia 1991, 5:249-254.
15. Lange B.J., Yang R.K., Gan J., Hank J.A., Sievers E.L., Alonzo T.A., et al. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia. Pediatr Blood Cancer 2011, 57:398-405.
16. Cimino G., Amadori S., Cava M.C., De Sanctis V., Petti M.C., Di Gregorio A.O., et al. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients. Leukemia 1991, 5:32-35.
17. Moon Y., Kim Y., Kim M., Lim J., Kang C.S., Kim W.I., et al. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia. Ann Clin Lab Sci 2004, 34:410-415.